Leukocare
Manufacturing · Germany · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Am Klopferspitz 19a, Martinsried / Munic...Phone Number
+49 8978016650Website
www.leukocare.comRevenue
$12.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Leukocare
Leukocare AG, headquartered in Munich, Germany, is a biotechnology company that specializes in the field of bio-pharmaceutical formulation development.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Leukocare your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Leukocare
Check if Leukocare has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Leukocare has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Leukocare, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Leukocare is spiking on competitors!
Click to see if Leukocare had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Leukocare launches new products
Earning: See what the market has to say on Leukocare recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Leukocare as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Leukocare is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Leukocare is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Leukocare.
Leukocare financials insights
Gather financial insights about Leukocare, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Unspecified
$17.5M
Leukocare Tech Stack
A closer look at the technologies used by Leukocare
See more technologies
Most Recent Scoops
Event
Product Marketing, Events, Engineering, Sales, Search, Bioengineering, Medical Research, Pharmaceuticals, Field /Outside Sales, Clinical Operations, Field Marketing, Operations
Left Company
Executive Move
Executive Moves, Left Company
Funding
New Hire
Executive Move
Cornelius Pompe has been named Vice President, Research & Development. Previously, Pompe served as Process Development Principal Scientist at Amgen.
Left Company
Executive Move
Leukocare News & Media
Rentschler Biopharma and Leukocare extend service offering with joint U.S. site
LAUPHEIM, Germany and MARTINSRIED, Germany, and MILFORD, Mass., March 22, 2021 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Leukocare AG, a German biotechnology company specialized in the field of biopharmaceutical formulation development, celebrate the fourth anniversary of their unique strategic alliance. Established in 2017 and recently expanded into the U.S., this highly successful alliancACTIVE BIOTECH ENTERS INTO A MANUFACTURING AGREEMENT WITH FAMAR HEALTH CARE SERVICES FOR NEW FORMULATION OF LAQUINIMOD
Active Biotech AB (publ) (NASDAQ STOCKHOLM: ACTI) today announced it has reached a manufacturing agreement with Famar Health Care Services Madrid SAU (“Famar”), a European provider of pharmaceutical manufacturing and development services. Famar will deliver clinical trial material of the newly developed eye-drop formulation of laquinimod.Leukocare starts operations in the US and opens development laboratories and offices in Boston Metropolitan Area
MARTINSRIED, Germany and MUNICH, Germany and MILFORD, Mass., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, today announced the opening of its development laboratories and offices in Milford, MA, USA. The recently incorporated Leukocare Inc., a wholly owned subsidiary of Leukocare AG, lays the foundation for supporting US based clients on site and further strengthens Leukocare´s posiReiThera, LEUKOCARE and Univercells Announce Pan-European Consortium for the Fast-track Development of a Single-dose Adenovirus-based COVID-19 Vaccine
ROME, MUNICH and BRUSSELS, April 23, 2020 /PRNewswire/ -- Italian ReiThera Srl. (Rome), German LEUKOCARE AG (Munich), and Belgian Univercells S.A. (Brussels), today announced a strategic collaboration for the development and large-scale manufacturing of a novel adenoviral vector-based...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Leukocare
Sign Up For FreeTo access detailed company insights
Leukocare AG, headquartered in Munich, Germany, is a biotechnology company that specializes in the field of bio-pharmaceutical formulation development.... Read More
